Navigation Links
'Museomics' yields new insights into extinct Tasmanian tiger

January 13, 2009 In 1902, the National Zoo in Washington D.C. arranged to have a unique and endangered animal called the thylacine, or Tasmanian Tiger, brought to the United States from Tasmania. Later that year, a female and her three cubs arrived at the zoo. However, by the mid-1930s, the thylacine was extinct, leaving behind only preserved museum specimens. In a study published online today in Genome Research (, researchers have used state-of-the-art DNA sequencing technology to analyze preserved thylacines, including one of those brought to the National Zoo more than 100 years ago, making novel discoveries in thylacine genomics and the burgeoning field of "museomics."

The thylacine was actually not a tiger at all, rather a marsupial with many dog-like featuresa striking example of convergent evolution in mammals. Extensively hunted by farmers, the thylacine was becoming increasingly rare in the wild at the time the National Zoo acquired the female and cubs, and was declared extinct in 1936 upon the death of the last captive animal. Genetic sequences sampled from the preserved specimens of the National Zoo thyalcine family have been studied in recent years, however these investigations were severely limited by DNA contamination and degradation.

Now, in a strategy nicknamed "museomics," researchers are using improved methods for sampling DNA combined with the latest sequencing technology to analyze preserved museum samples. In this study, an international team of scientists has sequenced mitochondrial and nuclear DNA from the hair of the male thylacine offspring brought to the National Zoo in 1902 and a female that died in the London Zoo in 1893. In addition to refining the place of this unusual animal in evolutionary history, genetic clues to the impending extinction of the thylacine became apparent.

"What I find amazing is that the two specimens are so similar," said Dr. Anders Gtherstrm of Uppsala University in Sweden. "There is very little genetic variation between them." Gtherstrm, a co-author of the study, explained that a lack of genetic diversity is indicative of a species on the brink of extinction, and we are now observing this more than 70 years later.

In addition to using the mitochondrial genome sequence to study the phylogeny of the thylacine, the authors also investigated the collection of genetic material of microbial and viral origin (the "metagenome") present on the museum samples. Interestingly, the research team found distinct differences in the microbial content of the hair of the wild-born thylacine from the London Zoo and the captive-born thylacine from the National Zoo. Furthermore, the authors noted that the specimens were preserved by differing methods. "Analyzing the microbial content of museum specimens will therefore allow us to gain insight into the microbial flora that lives on the exhibit samples and help to develop means to further protect them," said Dr. Stephan Schuster of Penn State University, also an author of the report.

This work has established the groundwork for more detailed genetic analysis of the thylacine, opened the door to more museomic studies using the treasure trove of museum specimens worldwide, and will raise dialogue about even bigger projects. "The large amount of mitochondrial and nuclear DNA gained in our study demonstrates the feasibility of a thylacine genome project," explained Schuster. "It will also revive discussions on the possible resurrection of the animal."


Contact: Peggy Calicchia
Cold Spring Harbor Laboratory

Related biology technology :

1. Sea urchin yields a key secret of biomineralization
2. Pioneer(R) Brand Soybeans From DuPont Deliver Step-Change in Soybean Yields
3. DNA technique yields 3-D crystalline organization of nanoparticles
4. Collaboration yields the right glasses for observing mystery behavior in electrons
5. Jatropha Sector Reality Check: Still Viable In Volatile Times? Upcoming Webcast Shares Latest Insights
6. European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTrends Report
7. Protein Research Marketing Insights
8. Microsurgery on the brain of the fruit fly leads to new insights into irreparable nerve injuries
9. Peripheral Vascular Device Market Insights Webinar
10. New insights into cellular reprogramming revealed by genomic analysis
11. Pharmaceuticals & Biotechs to Share Insights for Developing Leaders in a Fast-Paced, Competitive Industry
Post Your Comments:
Related Image:
'Museomics' yields new insights into extinct Tasmanian tiger
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris ... that its business and prospects remain fundamentally strong ... Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation to ... completion following review of the final interim efficacy ... 2 Primary Endpoint in men with heavily pretreated ...
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... ... genomics company uBiome, were featured on AngelList early in their initial angel funding ... an AngelList syndicate for individuals looking to make early stage investments in the ...
(Date:11/24/2015)... 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will ... New York on Wednesday, December 2 at 9:30 a.m. ... and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola ... a corporate overview. --> th Annual Oppenheimer Healthcare ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... of IIROC on behalf of the Toronto Stock Exchange, ... release there are no corporate developments that would cause ... --> --> About Aeterna ... . --> Aeterna Zentaris is a ...
Breaking Biology Technology:
(Date:11/18/2015)... Nov. 18, 2015  As new scientific discoveries deepen ... and other healthcare providers face challenges in better using ... patients. In addition, as more children continue to survive ... adulthood and old age. John M. Maris, ... Hospital of Philadelphia (CHOP) . --> ...
(Date:11/17/2015)... , Nov. 17, 2015 Pressure BioSciences, Inc. ... the development and sale of broadly enabling, pressure cycling ... sciences industry, today announced it has received gross proceeds ... million Private Placement (the "Offering"), increasing the total amount ... or more additional closings are expected in the near ...
(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
Breaking Biology News(10 mins):